Skip to main content

Wellington Management — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

282
Companies
$78.3B
Total invested
$277.6M
Avg. check
65
Industries
Biotechnology 10Health Care 9Therapeutics 5Pharmaceutical 3Artificial Intelligence (AI) 3Biopharma 2+59 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97–120 of 282
MBX Biosciences
August 2024

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Biotechnology · Carmel$63.5M Series C
Day One Biopharmaceuticals
July 2024

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Biopharma · South San Francisco$175.0M Post-IPO Equity
Hyzon Motors
July 2024

Hyzon Motors is a global supplier of hydrogen fuel-cell powered commercial vehicles.

Automotive · Honeoye$4.5M Post-IPO Equity
Scorpion Therapeutics
July 2024

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Biotechnology · Boston$150.0M Series C
TS Conductor
July 2024

TS Conductor specializes in high-performance conductors that increase the ampacity of electric transmission and distribution.

Electrical Distribution · Arcadia$60.0M Series B
Entrada Therapeutics
June 2024

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Biotechnology · Boston$100.0M Post-IPO Equity
GrayMatter Robotics
June 2024

GrayMatter Robotics provides AI-powered robotic solutions that enhance productivity and efficiency for high-mix manufacturers.

Artificial Intelligence (AI) · Gardena$45.0M Series B
CARGO Therapeutics
May 2024

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Biotechnology · San Mateo$110.0M Post-IPO Equity
Peloton
May 2024

Peloton is an interactive fitness platform reinventing fitness with live and on-demand boutique studio classes.

Cycling · New York$300.0M Post-IPO Debt
Bluejay Therapeutics
May 2024

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

Biotechnology · San Mateo$182.0M Series C
Meati
May 2024

Meati Foods is a consumer goods company that provides fungi-based meat alternatives to everyone.

Alternative Protein · Boulder$100.0M Series C
BBOT
May 2024

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

Biopharma · Palo Alto$200.0M Venture - Series Unknown
WeWork
April 2024

WeWork is a platform for creators that transforms buildings into dynamic environments for creativity, focus, and collaboration.

Commercial Real Estate · New York$450.0M Post-IPO Equity
Finvero
April 2024

Finvero is a fintech company, operating a consumer Lending MarketPlace Platform (SaaS format) connecting merchants, shoppers and lenders.

Consumer Lending · Mexico City$3.8M Venture - Series Unknown
Asher Bio
April 2024

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

Biotechnology · San Francisco$55.0M Series C
Arcadia
April 2024

Arcadia is the global utility data and energy solutions platform.

Charging Infrastructure · Washington$50.0M Series E
Acrivon Therapeutics
April 2024

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Biotechnology · Cambridge$130.0M Post-IPO Equity
Obsidian Therapeutics
April 2024

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Biotechnology · Cambridge$160.5M Series C
BetterUp
February 2024

BetterUp provides AI and human coaching to improve leadership, management, and employee performance across organizations.

Artificial Intelligence (AI) · San Francisco$215K Venture - Series Unknown
Voyager Therapeutics
January 2024

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Biotechnology · Cambridge$100.0M Post-IPO Equity
Binkey
December 2023

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Financial Services · Washington$3.3M Seed
Arrival
November 2023

Arrival is a developer and manufacturer of zero-emission, public transportation vehicles.

Automotive · London$50.0M Post-IPO Debt
Attentive
August 2023

Attentive is a personalized mobile messaging platform that facilitates businesses with AI powered SMS and e-mail marketing solutions.

Artificial Intelligence (AI) · HobokenSecondary Market
Trove
August 2023

Trove, commanding 75% of U.S. branded resale, empowers brands like Patagonia and Michael Kors to launch, manage, and scale resale programs

E-Commerce · Brisbane$30.0M Series E

Where Wellington Management invests

Biotechnology10
Health Care9
Therapeutics5
Pharmaceutical3
Artificial Intelligence (AI)3
Biopharma2

About Wellington Management's portfolio

How many companies has Wellington Management invested in?▸

Wellington Management has invested in 282 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Wellington Management invest in?▸

Wellington Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Artificial Intelligence (AI). The firm invests across 65 different industry categories.

What is Wellington Management's largest investment?▸

Among tracked funding rounds, WeWork received $450.0M in a Post-IPO Equity round. Wellington Management's total known invested capital is $78.3B.

What is the average investment size for Wellington Management?▸

Wellington Management's average investment size is $277.6M across its portfolio of 282 companies.

What are Wellington Management's most recent investments?▸

Recent Wellington Management portfolio additions include MBX Biosciences, Day One Biopharmaceuticals, Hyzon Motors, Scorpion Therapeutics, TS Conductor. These companies were founded in 2020 or later.

Reach the founders behind these 282 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →